ADME

R&D

Beyond GLP-1: Preclinical hurdles and solutions for next-gen...

The development experience with GLP-1 analogues offers critical insights for navigating ADME challenges in contemporary peptide programmes.

Partner Content

Partner Content

Less than 3 weeks to SMi's 3rd Annual Drug Discovery Chemist...

3 weeks to SMi's 3rd Annual Drug Discovery Chemistry

Partner Content

Exclusive insights into the latest innovations at Drug Disco...

Exclusive insights into the latest innovations

Partner Content

Partner Content

Speaker Interview with Pau Aceves Released - SMi’s ADMET Eve...

The 13th annual ADMET conference is returning to London, UK for an in-depth exploration of the optimisation of ADMET modelling techniques, preclinical DMPK applications and the development of bioph

Beyond GLP-1: Preclinical hurdles and solutions for next-gen...

Less than 3 weeks to SMi's 3rd Annual Drug Discovery Chemist...

Exclusive insights into the latest innovations at Drug Disco...

Speaker Interview with Pau Aceves Released - SMi’s ADMET Eve...

Aspen, Bambusa close IPOs as Corxel takes SPAC route

Discover a new era of healthcare panel engagement: Grounded ...

ADME

Editor's Picks